Skip to main content
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1975 Apr;51(594):236–239. doi: 10.1136/pgmj.51.594.236

Hirsutism

D R London
PMCID: PMC2495956  PMID: 1197153

Abstract

Hirsutism is usually caused either by an increase in androgen production by the ovary or adrenal or it may be due to increased sensitivity of the hair follicle to normal amounts of circulating androgens. The diagnostic possibilities can be resolved on clinical grounds by laparoscopy and by hormone measurements. The commonest causes of this symptom are ‘idiopathic hirsutism’ and the polycystic ovary syndrome. Treatment is of the underlying condition or, when that is not possible, by local removal of hair or by the administration of oral contraceptives or glucocorticoids.

Full text

PDF
236

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson D. C. Sex-hormone-binding globulin. Clin Endocrinol (Oxf) 1974 Jan;3(1):69–96. doi: 10.1111/j.1365-2265.1974.tb03298.x. [DOI] [PubMed] [Google Scholar]
  2. Burke C. W., Anderson D. C. Sex-hormone-binding globulin is an oestrogen amplifier. Nature. 1972 Nov 3;240(5375):38–40. doi: 10.1038/240038a0. [DOI] [PubMed] [Google Scholar]
  3. CROOKE A. C., BUTT W. R., PALMER R., MORRIS R., EDWARDS R. L., TAYLOR C. W., SHORT R. V. Effect of human pituitaryfollicle-stimulating hormone and chorionic vonadotrophin in Stein-Leventhal syndrome. Br Med J. 1963 Apr 27;1(5338):1119–1123. doi: 10.1136/bmj.1.5338.1119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Ettinger B., Goldfield E. B., Burrill K. C., Von Werder K., Forsham P. H. Plasma testosterone stimulation-suppression dynamics in hirsute women. correlation with long-term therapy. Am J Med. 1973 Feb;54(2):195–200. doi: 10.1016/0002-9343(73)90223-4. [DOI] [PubMed] [Google Scholar]
  5. Gomez E. C., Hsia S. L., Frost P. Cutaneous transformation of testosterone into 5 -androstane-3 ,17 -diol. J Clin Endocrinol Metab. 1972 Feb;34(2):417–419. doi: 10.1210/jcem-34-2-417. [DOI] [PubMed] [Google Scholar]
  6. Gomez E. C., Hsia S. L. In vitro metabolism of testosterone-4-14C and delta-4-androstene-3,17-dione-4-14C in human skin. Biochemistry. 1968 Jan;7(1):24–32. doi: 10.1021/bi00841a004. [DOI] [PubMed] [Google Scholar]
  7. Mauvais-Jarvis P., Charransol G., Bobas-Masson F. Simultaneous determination of urinary androstanediol and testosterone as an evaluation of human androgenicity. J Clin Endocrinol Metab. 1973 Mar;36(3):452–459. doi: 10.1210/jcem-36-3-452. [DOI] [PubMed] [Google Scholar]
  8. SHIPPEL S. The ovarian theca cell. IV. The hyperthecosis syndrome. J Obstet Gynaecol Br Emp. 1955 Jun;62(3):321–353. doi: 10.1111/j.1471-0528.1955.tb14148.x. [DOI] [PubMed] [Google Scholar]
  9. Short R. V., London D. R. Defective Biosynthesis of Ovarian Steroids in the Stein-Leventhal Syndrome. Br Med J. 1961 Jun 17;1(5241):1724–1727. doi: 10.1136/bmj.1.5241.1724. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Yen S. S., Vela P., Rankin J. Inappropriate secretion of follicle-stimulating hormone and luteinizing hormone in polycystic ovarian disease. J Clin Endocrinol Metab. 1970 Apr;30(4):435–442. doi: 10.1210/jcem-30-4-435. [DOI] [PubMed] [Google Scholar]
  11. Zárate A., Canales E. S., Schally A. V., Ayala-Valdés L., Kastin A. J. Successful induction of ovulation with synthetic luteinizing hormone-releasing hormone in anovulatoy infertility. Fertil Steril. 1972 Sep;23(9):672–674. doi: 10.1016/s0015-0282(16)39196-8. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES